EUR-Lex & EU Commission AI-Powered Semantic Search Engine
Modern Legal
  • Query in any language with multilingual search
  • Access EUR-Lex and EU Commission case law
  • See relevant paragraphs highlighted instantly
Start free trial

Similar Documents

Explore similar documents to your case.

We Found Similar Cases for You

Sign up for free to view them and see the most relevant paragraphs highlighted.

Case T-713/21: Action brought on 5 November 2021 — Agentur für Globale Gesundheitsverantwortung v EMA

ECLI:EU:UNKNOWN:62021TN0713

62021TN0713

November 5, 2021
With Google you find a lot.
With us you find everything. Try it now!

I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!

Valentina R., lawyer

14.2.2022

Official Journal of the European Union

C 73/47

(Case T-713/21)

(2022/C 73/60)

Language of the case: German

Parties

Applicant: Agentur für Globale Gesundheitsverantwortung (Elsbethen, Austria) (represented by: A. Steindl, lawyer)

Defendant: European Medicines Agency

Form of order sought

The applicant claims that the Court should:

annul the EMA’s decision of 21 September 2021 (EMA/468888/2021) rejecting the applicant’s appeal of 13 August 2021 against the EMA’s decision of 28 July 2021 (EMA/421922/2021);

grant access to the ‘c4591001-interim-ado-report-body’ study on the basis of which the EMA’s Assessment Report EMA/CHMP/282047/2021 Rev. 1 of 22 July 2021 or Commission Implementing Decision C(2021) 4034 (final) of 31 May 2021 were adopted.

Pleas in law and main arguments

In support of the action, the applicant relies on the following pleas in law.

1.First plea in law, alleging invalidity by reason of an error of law concerning the classification of anonymised data records of study C4591001 in respect of US participants in the study as personal data under Regulation 2018/7125. (1)

2.Second plea in law, alleging invalidity by reason of an error of law by the EMA in finding that study C4591001 has not been finalised as regards a change in the paediatric indication and is consistent with ‘EMA Policy(0070) on Clinical Data Publication’ (EMA/144064/2019).

3.Third plea in law, alleging invalidity by reason of an error of law in the finding that the first indent of Article 4(2) of Regulation No 1049/2001 (‘protection of commercial interests of a natural or legal person, including intellectual property’) is applicable.

4.Fourth plea in law, alleging invalidity by reason of an error of law in the finding that there is no overriding public interest pursuant to the last sentence of Article 4(2) of Regulation No 1049/2001.

*

Regulation (EU) 2018/1725 of the European Parliament and of the Council of 23 October 2018 on the protection of natural persons with regard to the processing of personal data by the Union institutions, bodies, offices and agencies and on the free movement of such data, and repealing Regulation (EC) No 45/2001 and Decision No 1247/2002/EC (OJ 2018 L 295, p. 39).

Regulation (EC) No 1049/2001 of the European Parliament and of the Council of 30 May 2001 regarding public access to European Parliament, Council and Commission documents (OJ 2001 L 145, p. 43).

EurLex Case Law

AI-Powered Case Law Search

Query in any language with multilingual search
Access EUR-Lex and EU Commission case law
See relevant paragraphs highlighted instantly

Get Instant Answers to Your Legal Questions

Cancel your subscription anytime, no questions asked.Start 14-Day Free Trial

At Modern Legal, we’re building the world’s best search engine for legal professionals. Access EU and global case law with AI-powered precision, saving you time and delivering relevant insights instantly.

Contact Us

Tivolska cesta 48, 1000 Ljubljana, Slovenia